Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial.

Senn N, Rarau P, Stanisic DI, Robinson L, Barnadas C, Manong D, Salib M, Iga J, Tarongka N, Ley S, Rosanas-Urgell A, Aponte JJ, Zimmerman PA, Beeson JG, Schofield L, Siba P, Rogerson SJ, Reeder JC, Mueller I.

PLoS Med. 2012;9(3):e1001195. doi: 10.1371/journal.pmed.1001195. Erratum in: PLoS Med. 2012 Jun;9(6). doi:10.1371/annotation/de06fdd3-c263-416c-8b5f-291f9c474558.

2.

Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.

Genton B, Baea K, Lorry K, Ginny M, Wines B, Alpers MP.

P N G Med J. 2005 Sep-Dec;48(3-4):141-50.

PMID:
17212060
3.

Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.

Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B.

Am J Trop Med Hyg. 2007 Nov;77(5):947-54.

4.

Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.

Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D.

Lancet. 2009 Oct 31;374(9700):1521-32. doi: 10.1016/S0140-6736(09)60997-1.

PMID:
19765815
5.

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.

Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C.

Lancet. 2009 Oct 31;374(9700):1533-42. doi: 10.1016/S0140-6736(09)61258-7. Review.

PMID:
19765816
6.

A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.

Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson PA, Abruquah HH, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer CG, Adjei O, May J.

Clin Infect Dis. 2007 Jul 1;45(1):16-25.

PMID:
17554695
7.

Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.

Konaté AT, Yaro JB, Ouédraogo AZ, Diarra A, Gansané A, Soulama I, Kangoyé DT, Kaboré Y, Ouédraogo E, Ouédraogo A, Tiono AB, Ouédraogo IN, Chandramohan D, Cousens S, Milligan PJ, Sirima SB, Greenwood BM, Diallo DA.

PLoS One. 2011;6(8):e23391. doi: 10.1371/journal.pone.0023391.

8.

Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.

Bukirwa H, Critchley J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004966. Review.

PMID:
16437507
9.

Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.

Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B, Chandramohan D.

PLoS One. 2008;3(12):e4000. doi: 10.1371/journal.pone.0004000.

10.

Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.

Rwagacondo CE, Niyitegeka F, Sarushi J, Karema C, Mugisha V, Dujardin JC, Van Overmeir C, van den Ende J, D'Alessandro U.

Am J Trop Med Hyg. 2003 Jun;68(6):743-7.

11.

Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.

Dicko A, Barry A, Dicko M, Diallo AI, Tembine I, Dicko Y, Dara N, Sidibe Y, Santara G, Conaré T, Chandramohan D, Cousens S, Milligan PJ, Diallo DA, Doumbo OK, Greenwood B.

PLoS One. 2011;6(8):e23390. doi: 10.1371/journal.pone.0023390.

12.

A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.

Mockenhaupt FP, Ehrhardt S, Dzisi SY, Teun Bousema J, Wassilew N, Schreiber J, Anemana SD, Cramer JP, Otchwemah RN, Sauerwein RW, Eggelte TA, Bienzle U.

Trop Med Int Health. 2005 Jun;10(6):512-20.

13.

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.

Kayentao K, Maiga H, Newman RD, McMorrow ML, Hoppe A, Yattara O, Traore H, Kone Y, Guirou EA, Saye R, Traore B, Djimde A, Doumbo OK.

Malar J. 2009 Jan 7;8:5. doi: 10.1186/1475-2875-8-5.

14.

Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.

Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N, Jaffar S, Baiden R, Hodgson A, Binka F, Greenwood B.

BMJ. 2005 Oct 1;331(7519):727-33.

15.

Malaria incidence and efficacy of intermittent preventive treatment in infants (IPTi).

Kobbe R, Adjei S, Kreuzberg C, Kreuels B, Thompson B, Thompson PA, Marks F, Busch W, Tosun M, Schreiber N, Opoku E, Adjei O, Meyer CG, May J.

Malar J. 2007 Dec 9;6:163.

16.

Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.

Crawley J, Sismanidis C, Goodman T, Milligan P; WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventive Treatment for malaria..

Lancet. 2012 Sep 15;380(9846):1001-10. doi: 10.1016/S0140-6736(12)60775-2.

PMID:
22850358
17.

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.

Dorsey G, Njama D, Kamya MR, Cattamanchi A, Kyabayinze D, Staedke SG, Gasasira A, Rosenthal PJ.

Lancet. 2002 Dec 21-28;360(9350):2031-8.

PMID:
12504399
18.

Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.

Nsimba B, Guiyedi V, Mabika-Mamfoumbi M, Mourou-Mbina JR, Ngoungou E, Bouyou-Akotet M, Loembet R, Durand R, Le Bras J, Kombila M.

Malar J. 2008 Feb 12;7:31. doi: 10.1186/1475-2875-7-31.

19.

Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.

Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ.

JAMA. 2007 May 23;297(20):2210-9.

PMID:
17519410
20.

Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.

Maiga H, Djimde AA, Beavogui AH, Toure O, Tekete M, Sangare CP, Dara A, Traore ZI, Traore OB, Dama S, N'Dong C, Niangaly H, Diallo N, Dembele D, Sagara I, Doumbo OK.

Malar J. 2015 Feb 7;14:64. doi: 10.1186/s12936-015-0557-y.

Supplemental Content

Support Center